140 related articles for article (PubMed ID: 9039219)
1. Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer.
Jyothirmayi R; Ramadas K; Varghese C; Jacob R; Nair MK; Sankaranarayanan R
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):373-6. PubMed ID: 9039219
[TBL] [Abstract][Full Text] [Related]
2. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.
van Zandwijk N; Dalesio O; Pastorino U; de Vries N; van Tinteren H
J Natl Cancer Inst; 2000 Jun; 92(12):977-86. PubMed ID: 10861309
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of second primary tumours in head and neck cancer in Europe: EUROSCAN.
de Vries N; Pastorino U; van Zandwijk N
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):367-8. PubMed ID: 7719218
[No Abstract] [Full Text] [Related]
4. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers].
Bairati I; Brochet F; Roy J; Gélinas M; Nabid A; Têtu B; Mâsse B; Meyer F
Bull Cancer Radiother; 1996; 83(1):12-6. PubMed ID: 8679274
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
[TBL] [Abstract][Full Text] [Related]
9. A population-based trial of beta-carotene chemoprevention of head and neck cancer.
Mayne ST; Zheng T; Janerich DT; Goodwin WJ; Fallon BG; Cooper DL; Friedman CD
Adv Exp Med Biol; 1992; 320():119-27. PubMed ID: 1442276
[No Abstract] [Full Text] [Related]
10. Adjuvant treatment of stage I lung cancer with high-dose vitamin A.
Pastorino U; Infante M; Maioli M; Chiesa G; Buyse M; Firket P; Rosmentz N; Clerici M; Soresi E; Valente M
J Clin Oncol; 1993 Jul; 11(7):1216-22. PubMed ID: 8391063
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention with interferon alfa and 13-cis retinoic acid in the adjunctive treatment of head and neck cancer.
Büntzel J; Küttner K
Auris Nasus Larynx; 1998 Dec; 25(4):413-8. PubMed ID: 9853666
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of head and neck cancer.
Huber MH; Lippman SM; Hong WK
Semin Oncol; 1994 Jun; 21(3):366-75. PubMed ID: 8209268
[No Abstract] [Full Text] [Related]
13. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
14. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
15. Retinoid chemoprevention of second primary tumors.
Benner SE; Lippman SM; Hong WK
Semin Hematol; 1994 Oct; 31(4 Suppl 5):26-30. PubMed ID: 7831582
[TBL] [Abstract][Full Text] [Related]
16. Retinoids as cancer-preventive agents.
Sankaranarayanan R; Mathew B
IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
[TBL] [Abstract][Full Text] [Related]
17. Retinoids in chemoprevention of head and neck carcinogenesis.
Lippman SM; Benner SE; Hong WK
Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
[TBL] [Abstract][Full Text] [Related]
18. [The chemoprevention of oral carcinoma with vitamin A and/or N-acetylcysteine].
Cianfriglia F; Iofrida RV; Calpicchio A; Manieri A
Minerva Stomatol; 1994 Jun; 43(6):255-61. PubMed ID: 7935276
[TBL] [Abstract][Full Text] [Related]
19. The EUROSCAN Study. EUROSCAN Steering Committee.
de Vries N; van Zandwijk N; Pastorino U
Br J Cancer; 1991 Dec; 64(6):985-9. PubMed ID: 1764390
[No Abstract] [Full Text] [Related]
20. [Usefulness of the administration of retinol palmitate to patients operated on for non-small-cell lung carcinoma in first 'A' stage].
Soresi E; Pastorino U; Chiesa G; Clerici M; Invernizzi G; Harari S; Brando B
Arch Monaldi Mal Torace; 1989; 44(4-6):731-7. PubMed ID: 2577790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
